Patent · US Expired

5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives

US6762189B1 · kind B1 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2002
Grant dateJul 13, 2004
Priority date
Expiry dateJul 3, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives, and more specifically, to 5-pyrimidinecarboxamide derivatives and their pharmacutically able salts, the process for preparing them, and the pharmaceutical compositions containing said compounds as active ingredients. In particular, said 5-pyrimidinecarboxamide derivatives of the present invention, due to their inhibitory activity against the proliferation of human immunodeficiency virus (HIV) as well as hepatitis B virus (HBV), can be used as a therapeutic agent as well as a preventive agent for hepatitis B and acquired immune deficiency syndrome (AIDS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.